Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Squamous Cell Carcinoma Antigen as a Marker of Sinonasal Inverted Papilloma
Brief Summary:
This prospective study aimed to evaluate the usefulness of squamous cell carcinoma antigen (SCCA) as a clinical marker of sinonasal inverted papilloma (IP). The potential benefit of SCCA in the diagnosis of unilateral nasal pathology and as a marker of hidden recurrence was evaluated as well.
Blood samples from patients with sinonasal IP were examined to determine serum SCCA levels before surgery, the day after surgery, and every 6 months during follow-up. Preoperative and postoperative levels of SCCA were compared.